ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,996.78
0.24%
US Tech 100
21,239.60
0.36%
Dow Jones
42,307.24
0.22%
Brent Oil
75.44
-0.79%
Bitcoin
104,234.16
-0.35%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vera Therapeutics Inc (VERA) Quote

Vera Therapeutics Inc

Vera Therapeutics Inc (VERA)

NASDAQ
20.635
-0.515
( -2.43% )
Updated: 13:10:10
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
20.635
Bid
20.62
Ask
20.66
Volume
516,666
20.60 Day's Range 21.21
18.53 52 Week Range 51.61
Market Cap
1.316B
Previous Close
21.15
Open
21.16
Last Trade
1
@
20.6447
Last Trade Time
13:10:24
Financial Volume
$ 10,818,167
VWAP
20.9384
Average Volume (3m)
1,741,945
Shares Outstanding
63,774,158
Dividend Yield
-
PE Ratio
-8.81
Earnings Per Share (EPS)
-2.39
Revenue
-
Net Profit
-152.15M

About Vera Therapeutics Inc

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
veratx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Vera Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VERA. The last closing price for Vera Therapeutics was $21.15. Over the last year, Vera Therapeutics shares have traded in a share price range of $ 18.53 to $ 51.61.

Vera Therapeutics currently has 63,774,158 shares outstanding. The market capitalization of Vera Therapeutics is $1.35 billion. Vera Therapeutics has a price to earnings ratio (PE ratio) of -8.81.

Ask ADVFN Intelligence (AI)

VERA Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 03 2025
VERA (-2.43%)

Form 8-K - Current report
Edgar (US Regulatory)
June 02 2025
VERA (-2.43%)

Form 8-K - Current report
Edgar (US Regulatory)
May 06 2025
VERA (-2.43%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 03 2025
VERA (-2.43%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 03 2025
VERA (-2.43%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 28 2025
VERA (-2.43%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 28 2025
VERA (-2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 27 2025
VERA (-2.43%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.035-8.9766210851322.6723.2520.6147296122.1217222CS
4-0.215-1.0311750599520.853318.76301693725.75338072CS
12-6.515-23.996316758727.153318.53174194524.28697377CS
26-23.175-52.898881533943.8145.0618.53127338227.15545407CS
52-15.085-42.231243001135.7251.6118.5395100831.96736978CS
1566.58546.868327402114.0551.615.272226226.76840665CS
2609.22580.850131463611.4151.615.254911726.50738336CS

VERA - Frequently Asked Questions (FAQ)

What is the current Vera Therapeutics share price?
The current share price of Vera Therapeutics is $ 20.635
How many Vera Therapeutics shares are in issue?
Vera Therapeutics has 63,774,158 shares in issue
What is the market cap of Vera Therapeutics?
The market capitalisation of Vera Therapeutics is USD 1.35B
What is the 1 year trading range for Vera Therapeutics share price?
Vera Therapeutics has traded in the range of $ 18.53 to $ 51.61 during the past year
What is the PE ratio of Vera Therapeutics?
The price to earnings ratio of Vera Therapeutics is -8.81
What is the reporting currency for Vera Therapeutics?
Vera Therapeutics reports financial results in USD
What is the latest annual profit for Vera Therapeutics?
The latest annual profit of Vera Therapeutics is USD -152.15M
What is the registered address of Vera Therapeutics?
The registered address for Vera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vera Therapeutics website address?
The website address for Vera Therapeutics is veratx.com
Which industry sector does Vera Therapeutics operate in?
Vera Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
APVOAptevo Therapeutics Inc
$ 5.87
(108.16%)
112.86M
PTLEPTL Ltd
$ 0.4092
(106.77%)
358.94M
KWEKWESST Micro Systems Inc
$ 9.76
(69.44%)
33.71M
MRINMarin Software Incorporated
$ 1.4302
(68.26%)
20.74M
RELIReliance Global Group Inc
$ 3.265
(50.46%)
43.91M
CBIOCrescent Biopharma Inc
$ 15.5687
(-69.55%)
28.13k
PSTVPlus Therapeutics Inc
$ 0.1955
(-36.65%)
19.34M
EYENEyenovia Inc
$ 4.6599
(-33.14%)
5.95M
BMEABiomea Fusion Inc
$ 1.9399
(-33.11%)
6.98M
CEROCERo Therapeutics Holdings Inc
$ 13.855
(-30.13%)
2.31M
PTLEPTL Ltd
$ 0.4092
(106.77%)
358.94M
HCTIHealthcare Triangle Inc
$ 0.0254
(14.93%)
350.65M
GNLNGreenlane Holdings Inc
$ 0.01045
(0.48%)
179.98M
APVOAptevo Therapeutics Inc
$ 5.87
(108.16%)
112.86M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.3654
(3.56%)
95.02M

Discussion

View Full Feed
JennyMiller JennyMiller 4 minutes ago
So this isn’t just a one-off thing?
AHRO
deri21 deri21 4 minutes ago
$CNER bioEnergy Development Inc, creates two subsidiary companies to support growth
https://www.otcmarkets.com/stock/CNER/news/bioEnergy-Development-Inc-creates-two-subsidiary-companies-to-support-growth?id=483213
CNER
trade15 trade15 4 minutes ago
fung
Here's a fun fact for you. Urbie didn't start out planning Casavant Diamonds to be a scam . After his problems with the Alberta exchange over the acquisition of some claims originating from some of the PCBM crew. Not being the brightest bulb on the tree he made a deal for a shell for the
Crawfors Crawfors 4 minutes ago
It’s actually part of a broader strategy. Maybacks is building out its presence in ad-supported
streaming.

They already locked in Plex for their main channels — now they’re expanding into niche content like combat sports.

$AHRO
AHRO
Porch Honkey Porch Honkey 5 minutes ago
Great infor thanks.
GTCH
weedtrader420 weedtrader420 5 minutes ago
What’s up with all these stable coin stocks going up and crypto going down🤔🤑 CRCL SRM-TRON now JP Morgan coming out with its own stable coin
CRCL SRM
vlispxpert vlispxpert 5 minutes ago
I R W D sneaking up, no one (but us) is on it anywhere ;)
Crawfors Crawfors 6 minutes ago
oh hey Sport :)
PKTX
deri21 deri21 6 minutes ago
$CNER bioEnergy Development Inc, creates two subsidiary companies to support growth
https://www.otcmarkets.com/stock/CNER/news/bioEnergy-Development-Inc-creates-two-subsidiary-companies-to-support-growth?id=483213
CNER
littlejohn littlejohn 6 minutes ago
MURA 2.45, $5 to $6 /share cash value...

so we watch...LJ
MURA
JennyMiller JennyMiller 6 minutes ago
Combat sports? That’s a shift, isn’t it?
AHRO
Crawfors Crawfors 6 minutes ago
It's nice to see you! I was hoping to hear from you.
Yeah, it’s a new distribution deal through Maybacks, their entertainment arm. They’re teaming
up with Swerve Combat — a FAST channel that focuses on combat sports like boxing, MMA,
and wrestling. MMA is what I love :)
AHRO MMA
Calvin Hobbes Calvin Hobbes 6 minutes ago
$CDSG
https://x.com/MrHobbes488960/status/1932090069680267518
CDSG
vlispxpert vlispxpert 7 minutes ago
I R W D :)
Lime Time Lime Time 7 minutes ago
"GVSI will never get the books"

Sharp got the books.

"GVSI will never get Pink Current"

GVSI got Pink Current.

"GVSI is abandoned by Sharp"

GVSI is not abandoned. Pink Current and Sharp paying the OTCID fees. So now we enter
GVSI
Ribo Ribo 7 minutes ago
ePIC Blockchain Signs LOI with A.R.T. Digital

https://ih.advfn.com/stock-market/USOTC/code-green-apparel-pk-CGAC/stock-news/96268806/epic-blockchain-signs-loi-with-a-r-t-digital-to-r
CGAC
OzzieTrader OzzieTrader 7 minutes ago
Mate no hard feelings
It’s been a great back and forth with you today hope we have many many more over the coming years.
Signing off till the next time all, Shanghai Steve see you tomorrow mate the beers on you once you sell those 5000 shares of yours
Cheers
DTREF
LTListener LTListener 7 minutes ago
I believe a new formulation or delivery mechanism attached to an old compound would be patentable but they would also need to start at preclinical phase which would not even be considered until their more mature and prominent assets generate funding and flexibility to explore. At some point it woul
RSPI
skitahoe skitahoe 8 minutes ago
When I first heard the name Amgen it was about $15, I didn't buy, I watched it reach about $100 and split, I didn't think it could happen again, but it did. All totaled Amgen split a total of 48 to 1 in a decade. They were essentially splitting each time the shares went into triple digits.
NWBO
Patswil Patswil 8 minutes ago
That $34 price is based on warrants being exercise
The illegal warrants
FNMA
Frankher Frankher 8 minutes ago
IQSTEL ($IQST) and Cycurion ($CYCU) are actively preparing for a commercial launch in the second half of 2025, aiming to address the significant demand within the global cybersecurity market, projected to exceed $500 billion by 2030. Their combined expertise in AI and cybersecurity, coupled with IQS
CYCU IQST
DewDiligence DewDiligence 8 minutes ago
ZEAL.CO reports 28wk data for Dapiglutide, a dual GLP-1/GLP-2 agonist:

https://finance.yahoo.com/news/zealand-pharma-announces-positive-topline-152900038.html

At 28 weeks, the median placebo-adjusted weight loss (n=30) was 11.4%, which compares favorably to the 8.3% fig
Gatorca Gatorca 8 minutes ago
Koan looks like something going on, and some pumping on twitter x I see lol...
https://x.com/LBEquityAdvisor/status/1935369106888278241

https://x.com/SniperFlow777/status/1935381515766219173
EMGE
BlazingStocks BlazingStocks 8 minutes ago
$ILLR - The report highlights four major trends shaping influencer marketing: The Trust Factor, Small but Mighty: Micro & Nano Creators, Let the Community Create, Go Beyond One-Off Campaignshttps://finance.yahoo.com/news/julius-triller-launch-influencer-marketing-130000860.html
ILLR

Your Recent History

NASDAQ
VERA
Vera Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads